Literature DB >> 20200562

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

H S Gill1, J Söderholm, M R Prausnitz, M Sällberg.   

Abstract

The skin is potentially an excellent organ for vaccine delivery because of accessibility and the presence of immune cells. However, no simple and inexpensive cutaneous vaccination method is available. Micron-scale needles coated with DNA were tested as a simple, inexpensive device for skin delivery. Vaccination with a plasmid encoding hepatitis C virus nonstructural 3/4A protein using microneedles effectively primed specific cytotoxic T lymphocytes (CTLs). Importantly, the minimally invasive microneedles were as efficient in priming CTLs as more complicated or invasive delivery techniques, such as gene gun and hypodermic needles. Thus, microneedles may offer a promising technology for DNA vaccination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200562      PMCID: PMC2914565          DOI: 10.1038/gt.2010.22

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

1.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

Authors:  John A Mikszta; Jason B Alarcon; John M Brittingham; Diane E Sutter; Ronald J Pettis; Noel G Harvey
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

2.  Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.

Authors:  James A Matriano; Michel Cormier; Juanita Johnson; Wendy A Young; Margaret Buttery; Kofi Nyam; Peter E Daddona
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

3.  Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization.

Authors:  J H Cho; J W Youn; Y C Sung
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Authors:  Pierre Van Damme; Froukje Oosterhuis-Kafeja; Marie Van der Wielen; Yotam Almagor; Ofer Sharon; Yotam Levin
Journal:  Vaccine       Date:  2008-11-18       Impact factor: 3.641

Review 5.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 6.  Technical and regulatory hurdles for DNA vaccines.

Authors:  John Donnelly; Karin Berry; Jeffrey B Ulmer
Journal:  Int J Parasitol       Date:  2003-05       Impact factor: 3.981

7.  Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.

Authors:  L Frelin; M Alheim; A Chen; J Söderholm; B Rozell; C Barnfield; P Liljeström; M Sällberg
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

8.  Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.

Authors:  L Frelin; G Ahlén; M Alheim; O Weiland; C Barnfield; P Liljeström; M Sällberg
Journal:  Gene Ther       Date:  2004-03       Impact factor: 5.250

9.  Effect of microneedle design on pain in human volunteers.

Authors:  Harvinder S Gill; Donald D Denson; Brett A Burris; Mark R Prausnitz
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

10.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

Authors:  Daniel P Wermeling; Stan L Banks; David A Hudson; Harvinder S Gill; Jyoti Gupta; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

View more
  45 in total

1.  DNA vaccination in the skin using microneedles improves protection against influenza.

Authors:  Jae-Min Song; Yeu-Chun Kim; Eunju O; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

2.  Transdermal delivery devices: fabrication, mechanics and drug release from silk.

Authors:  Waseem K Raja; Scott Maccorkle; Izzuddin M Diwan; Abdurrahman Abdurrob; Jessica Lu; Fiorenzo G Omenetto; David L Kaplan
Journal:  Small       Date:  2013-05-08       Impact factor: 13.281

Review 3.  Microneedle Coating Methods: A Review with a Perspective.

Authors:  Rohan S J Ingrole; Harvinder Singh Gill
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

4.  Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Aswani Vunnava; Dae-Goon Yoo; Jae-Min Song; Mark R Prausnitz; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  The maximum possible amount of drug in rapidly separating microneedles.

Authors:  Dan Dan Zhu; Xiao Peng Zhang; Chang Bing Shen; Yong Cui; Xin Dong Guo
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

Review 6.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

7.  Kinetics of skin resealing after insertion of microneedles in human subjects.

Authors:  Jyoti Gupta; Harvinder S Gill; Samantha N Andrews; Mark R Prausnitz
Journal:  J Control Release       Date:  2011-05-26       Impact factor: 9.776

Review 8.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

9.  Measles vaccination using a microneedle patch.

Authors:  Chris Edens; Marcus L Collins; Jessica Ayers; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2012-10-05       Impact factor: 3.641

10.  Polymer multilayer tattooing for enhanced DNA vaccination.

Authors:  Peter C DeMuth; Younjin Min; Bonnie Huang; Joshua A Kramer; Andrew D Miller; Dan H Barouch; Paula T Hammond; Darrell J Irvine
Journal:  Nat Mater       Date:  2013-01-27       Impact factor: 43.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.